Koumoto J
Third Department of Internal Medicine, Okayama University Medical School.
Nihon Jinzo Gakkai Shi. 1992 Jul;34(7):789-99.
Three hundreds percutaneous renal biopsy cases were analyzed for recorded clinical complications retrospectively. Incidence of fever (> or = 37.5 degrees C), pain, and decrease in hematocrit (> or = 4%) was 21%, 28%, and 13% respectively. The incidence of fever and pain were less in the older patients. Prospectively, 125 cases who underwent ultrasonography following renal biopsies and 62 cases who underwent computerized tomography were analyzed. Bigger hematoma was followed by fever 5-7 days after renal biopsies. Incidence of pain and the decrease in hematocrit were correlated with the size of hematoma. Use of the ultrasonographic localization and a Tru-Cut biopsy needle or a Biopty-Cut needle decreased the incidence of hematoma more than 50ml following renal biopsy (0-5%). Incidence of fever and pain was less by these new procedure. The risk of hematoma increased as the biopsy needle went deeper into medulla.
回顾性分析300例经皮肾穿刺活检病例记录的临床并发症。发热(≥37.5℃)、疼痛和血细胞比容降低(≥4%)的发生率分别为21%、28%和13%。老年患者发热和疼痛的发生率较低。前瞻性分析了125例肾穿刺活检后接受超声检查的病例和62例接受计算机断层扫描的病例。较大血肿在肾穿刺活检后5 - 7天出现发热。疼痛发生率和血细胞比容降低与血肿大小相关。使用超声定位以及Tru-Cut活检针或Biopty-Cut针可使肾穿刺活检后血肿≥50ml的发生率降低至0 - 5%。采用这些新方法发热和疼痛的发生率较低。随着活检针进入髓质深度增加,血肿风险增加。